MESO

MKT CAP:$2B

Mesoblast Ltd

Market Cap

$2B

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$13.80-$4.36 (-24.01%)

Jun 8, 2026

52W High $20.9652W Low $10.16

Company Details

Mesoblast Limited, together with its subsidiaries, engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. The company's proprietary regenerative medicine technology platform...

CEO

—

IPO Date

Nov 13, 2015

Website

www.mesoblast.com

Key Metrics TTM

Revenue

$17M

+191.4% YoY

Net Income

-$102M

EPS (Diluted)

Free Cash Flow

-$50M

Revenue / Share

$0.14

Gross Margin

-208.5%

Operating Margin

-639.5%

Net Margin

-593.9%

FCF Margin

-292.7%

P/S

112.2x

P/E

Earnings Reports

Q4 2026

Aug 27, 2026

PENDING

FY 2025

Aug 29, 2025

$17M+191.4%

Q4 2025

Aug 29, 2025

$7M+458.6%

Q3 2025

May 30, 2025

$7M+458.6%

Q2 2025

Feb 28, 2025

$2M-6.8%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee